Daniel D. Shoemaker, Chief Scientific Officer at FATE THERAPEUTICS INC (FATE), sold 11,800 shares at $14.29 ($169K) on 2019-10-15, disclosed to the SEC on 2019-10-16.
Open-market sale of $169k FATE by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| FATE | SELL | 2020-11-16 | $2.6M | — | Filing → |
| FATE | SELL | 2020-09-16 | $1.8M | — | Filing → |
| FATE | SELL | 2020-01-10 | $118K | — | Filing → |